Abstract
Background: People who inject drugs (PWID) experience considerable unstable housing. Although unstable housing is associated with HIV and HCV infection among PWID, its contribution to transmission is unknown.
Methods: We developed country-level models of unstable housing and HIV/HCV transmission among PWID, calibrated to country-specific data on the prevalences of HIV/HCV and unstable housing. Based on our recently published systematic review, unstably housed PWID were assumed to have a 39% (95%CI: 6-84) and 64% (95%CI: 43-89%) increased risk of HIV and HCV transmission, respectively. Models estimated the population attributable fraction (PAF) of unstable housing to HIV and HCV transmission among PWID, defined as the percentage of infections prevented over 2020-2029 if the additional risk due to unstable housing was removed.
Findings: Models were produced for 58 countries with sufficient data (>66% of global PWID population). Globally, we project unstable housing contributes 7.9% (95% credibility interval [CrI] 2.3-15.7) and 11.2% (7.7-15.5) of new HIV and HCV infections among PWID over 2020-2029, respectively. Country-level PAFs were strongly associated with the prevalence of unstable housing. PAFs were greater in high-income countries (HIV:17.2%, 95%CrI:5.1-30.0; HCV:19.4%, 95%CrI:13.8-26.0) than in low or middle-income countries (HIV:6.6%, 95%CrI:1.8-13.1; HCV:8.3%, 95%CrI:5.5-11.7). PAFs were highest in Afghanistan, Czech Republic, India, USA, England and Wales where unstable housing contributed >20% of new HIV and HCV infections.
Interpretation: Unstable housing is an important modifiable risk factor for HIV/HCV transmission among PWID in many countries; emphasising the importance of implementing initiatives to mitigate the risks and reduce housing instability.
Funding: NIHR, NIAID/NIDA
Methods: We developed country-level models of unstable housing and HIV/HCV transmission among PWID, calibrated to country-specific data on the prevalences of HIV/HCV and unstable housing. Based on our recently published systematic review, unstably housed PWID were assumed to have a 39% (95%CI: 6-84) and 64% (95%CI: 43-89%) increased risk of HIV and HCV transmission, respectively. Models estimated the population attributable fraction (PAF) of unstable housing to HIV and HCV transmission among PWID, defined as the percentage of infections prevented over 2020-2029 if the additional risk due to unstable housing was removed.
Findings: Models were produced for 58 countries with sufficient data (>66% of global PWID population). Globally, we project unstable housing contributes 7.9% (95% credibility interval [CrI] 2.3-15.7) and 11.2% (7.7-15.5) of new HIV and HCV infections among PWID over 2020-2029, respectively. Country-level PAFs were strongly associated with the prevalence of unstable housing. PAFs were greater in high-income countries (HIV:17.2%, 95%CrI:5.1-30.0; HCV:19.4%, 95%CrI:13.8-26.0) than in low or middle-income countries (HIV:6.6%, 95%CrI:1.8-13.1; HCV:8.3%, 95%CrI:5.5-11.7). PAFs were highest in Afghanistan, Czech Republic, India, USA, England and Wales where unstable housing contributed >20% of new HIV and HCV infections.
Interpretation: Unstable housing is an important modifiable risk factor for HIV/HCV transmission among PWID in many countries; emphasising the importance of implementing initiatives to mitigate the risks and reduce housing instability.
Funding: NIHR, NIAID/NIDA
| Original language | English |
|---|---|
| Pages (from-to) | e136-e145 |
| Number of pages | 10 |
| Journal | Lancet Public Health |
| Volume | 7 |
| Issue number | 2 |
| Early online date | 7 Jan 2022 |
| DOIs | |
| Publication status | Published - 1 Feb 2022 |
Bibliographical note
Funding Information:The study was funded by the US National Institute of Allergy and Infectious Diseases (NIAID) and National Institute for Drug Abuse (NIDA; R01AI147490). JS, MH, PV, and HF acknowledge support from the National Institute of Health (NIH) Research Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol. JS and PV acknowledge funding from NIDA (R01DA033679, R21 DA047902). AA is supported through postdoctoral fellowships through the Canadian Institute of Health Research, Fonds de recherche du Québec – Santé and Canadian Network on Hepatitis C. LD is supported by a National Health and Medical Research Council Senior Principal Research Fellowship (1135991) and a US NIH NIDA grant (R01DA1104470).
Funding Information:
The study was funded by the US National Institute of Allergy and Infectious Diseases (NIAID) and National Institute for Drug Abuse (NIDA; R01AI147490). JS, MH, PV, and HF acknowledge support from the National Institute of Health (NIH) Research Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol. JS and PV acknowledge funding from NIDA (R01DA033679, R21 DA047902). AA is supported through postdoctoral fellowships through the Canadian Institute of Health Research, Fonds de recherche du Qu?bec ? Sant? and Canadian Network on Hepatitis C. LD is supported by a National Health and Medical Research Council Senior Principal Research Fellowship (1135991) and a US NIH NIDA grant (R01DA1104470). Editorial note: the Lancet Group takes a neutral position with respect to territorial claims in published maps and institutional affiliations.
Publisher Copyright:
© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Groups and Themes
- GEM-B
Fingerprint
Dive into the research topics of 'The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study'. Together they form a unique fingerprint.Equipment
-
HPC (High Performance Computing) and HTC (High Throughput Computing) Facilities
Alam, S. R. (Manager), Williams, D. A. G. (Manager), Eccleston, P. E. (Manager) & Greene, D. (Manager)
Facility/equipment: Facility
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver